Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Schoof

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Brain Pathology (Zurich, Switzerland)|June 17, 2025
Integration of omics data in the diagnosis and therapy of glioblastomaConstantin Möller, Melanie Schoof, Keith L Ligon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2024
SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic CerebellumCarolin Göbel, Melanie Schoof, Dörthe Holdhof, et al.
Cerebellum (London, England)|January 2, 2021
Simultaneous Brg1 Knockout and MYCN Overexpression in Cerebellar Granule Neuron Precursors Is Insufficient to Drive Tumor Formation but Temporarily Enhances their Proliferation and Delays their MigrationDörthe Holdhof, Ji Hoon On, Melanie Schoof, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 11, 2019
hGFAP-Positive Stem Cells Depend on Brg1 for Proper Formation of Cerebral and Cerebellar StructuresDörthe Holdhof, Melanie Schoof, Malte Hellwig, et al.
Iscience|August 23, 2023
<i>hGFAP</i>-mediated <i>GLI2</i> overexpression leads to early death and severe cerebellar malformations with rare tumor formationJudith Niesen, Irm Hermans-Borgmeyer, Christina Krüger, et al.
Brain Pathology (Zurich, Switzerland)|December 30, 2022
Generation of new transgenic SMARCA4-deficient mouse models results in neuromuscular weakness and paralysis of limbsSina Neyazi, Lea Altendorf, Dora Schwetje, et al.
Acta Neuropathologica|July 15, 2021
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndromeMelanie Schoof, Uwe Kordes, Alexander E Volk, et al.
Neuro-Oncology|November 22, 2025
Single-nucleus transcriptomics of spinal ependymoma subtypes recognizes intratumoral heterogeneityKaroline Hack, Saskia-Larissa Jauch-Speer, Catena Kresbach, et al.
BMC Bioinformatics|September 23, 2025
CCNV: a user-friendly R package enabling large-scale cumulative copy number variation analyses of DNA methylation dataAntonia Gocke, Yannis Schumann, Jelena Navolić, et al.
Acta Neuropathologica Communications|November 3, 2023
MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in miceCarolin Göbel, Shweta Godbole, Melanie Schoof, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Brain Pathology (Zurich, Switzerland)|June 17, 2025
Integration of omics data in the diagnosis and therapy of glioblastomaConstantin Möller, Melanie Schoof, Keith L Ligon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2024
SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic CerebellumCarolin Göbel, Melanie Schoof, Dörthe Holdhof, et al.
Cerebellum (London, England)|January 2, 2021
Simultaneous Brg1 Knockout and MYCN Overexpression in Cerebellar Granule Neuron Precursors Is Insufficient to Drive Tumor Formation but Temporarily Enhances their Proliferation and Delays their MigrationDörthe Holdhof, Ji Hoon On, Melanie Schoof, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 11, 2019
hGFAP-Positive Stem Cells Depend on Brg1 for Proper Formation of Cerebral and Cerebellar StructuresDörthe Holdhof, Melanie Schoof, Malte Hellwig, et al.
Iscience|August 23, 2023
<i>hGFAP</i>-mediated <i>GLI2</i> overexpression leads to early death and severe cerebellar malformations with rare tumor formationJudith Niesen, Irm Hermans-Borgmeyer, Christina Krüger, et al.
Brain Pathology (Zurich, Switzerland)|December 30, 2022
Generation of new transgenic SMARCA4-deficient mouse models results in neuromuscular weakness and paralysis of limbsSina Neyazi, Lea Altendorf, Dora Schwetje, et al.
Acta Neuropathologica|July 15, 2021
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndromeMelanie Schoof, Uwe Kordes, Alexander E Volk, et al.
Neuro-Oncology|November 22, 2025
Single-nucleus transcriptomics of spinal ependymoma subtypes recognizes intratumoral heterogeneityKaroline Hack, Saskia-Larissa Jauch-Speer, Catena Kresbach, et al.
BMC Bioinformatics|September 23, 2025
CCNV: a user-friendly R package enabling large-scale cumulative copy number variation analyses of DNA methylation dataAntonia Gocke, Yannis Schumann, Jelena Navolić, et al.
Acta Neuropathologica Communications|November 3, 2023
MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in miceCarolin Göbel, Shweta Godbole, Melanie Schoof, et al.
Pageof 4